Alamar Biosciences Inc.
ALMR | NASDAQ
$29.20
-$1.40 (-4.58%)
Nov 2, 2026, 12:07 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -13.2M | -21.33M |
Depreciation & Amortization | 1.13M | 1.17M |
Stock-Based Compensation | n/a | n/a |
Other Working Capital | -4.41M | -4.61M |
Other Non-Cash Items | 5.52M | 11.2M |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -4.78M | -11.39M |
Operating Cash Flow | -11.32M | -20.35M |
Capital Expenditures | -3.64M | -600K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | -117.05M | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -120.8M | -778K |
Debt Repayment | n/a | 56.18M |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | n/a | n/a |
Financial Cash Flow | 201.84M | 55.76M |
Net Cash Flow | 68.38M | 64.59M |
Free Cash Flow | -14.96M | -20.95M |
Adj. Free Cash Flow | -14.96M | -20.95M |
Maintenance CapEx | -1.13M | -600K |
Growth CapEx | -2.51M | n/a |
Owner Earnings | -12.46M | -20.95M |
Add to Watchlist
Select watchlists to add or remove ALMR